Future Industry Investment Fund II (Limited Partnership) (先进制造产业投资基金二期 (有限合伙))于2026年8月7日以每股均价13.74港元卖出药捷安康-B 177.30万股H股,涉资约2436.10万港元。
该基金此次减持前持有药捷安康-B好仓2006.33万股,占比6.42%;减持后持股量为1829.03万股,好仓比例降至5.85%。
Future Industry Investment Fund II (Limited Partnership) (先进制造产业投资基金二期 (有限合伙))于2026年8月7日以每股均价13.74港元卖出药捷安康-B 177.30万股H股,涉资约2436.10万港元。
该基金此次减持前持有药捷安康-B好仓2006.33万股,占比6.42%;减持后持股量为1829.03万股,好仓比例降至5.85%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.